Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New revision v3.3.2 was added to the Record History and revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:10:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The government funding notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T18:31:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The latest version updates core study details including recruitment status, study status, study design, and contact/locations. This affects how users track trial progress and locate study sites.
    Difference
    0.1%
    Check dated 2025-11-03T13:17:43.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Major update to page content reflecting current operating status and a version bump to v3.2.0; removes the old v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-06T04:14:06.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.3%
    Check dated 2025-09-28T23:35:11.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the ‘Back to Top’ element was removed. Overall, these are minor UI/versioning changes with no impact on core content, pricing, availability, or scheduling.
    Difference
    0.8%
    Check dated 2025-09-14T09:53:50.000Z thumbnail image

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.